News
Important Only
Stoke Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Stoke Therapeutics Inc STOK.OQ reported a quarterly adjusted loss of 40 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -46 cents. The mean expectation of ten analysts for the quarter was for a loss of 51 cents per share. Wal...Reuters
Tue, Aug 12
Cognition Therapeutics rises on FDA support for late-stage trials of Alzheimer’s drug
** Shares of drug developer Cognition Therapeutics rise 16.4% to $1.28 in extended trading ** Cognition Therapeutics is developing an experimental pill called zervimesine to treat patients with Alzheimer’s disease** CGTX says FDA agreed that Cognition can focus their studies on patients with mild-to...Reuters
Tue, Aug 12
Oric Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Oric Pharmaceuticals Inc ORIC.OQ reported a quarterly adjusted loss of 47 cents per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -45 cents. The mean expectation of ten analysts for the quarter was for a loss of 44 cents per share. Wa...Reuters
Tue, Aug 12
Onkure Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Onkure Therapeutics Inc OKUR.OQ reported a quarterly adjusted loss of $1.14 per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-1.60. The mean expectation of five analysts for the quarter was for a loss of $1.25 per share. Wall Stree...Reuters
Tue, Aug 12
Lyell Immunopharma Inc reports results for the quarter ended June 30 - Earnings Summary
Lyell Immunopharma Inc LYEL.OQ reported a quarterly adjusted loss of $2.89 per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-3.60. The mean expectation of three analysts for the quarter was for a loss of $3.58 per share. Wall Stree...Reuters
Tue, Aug 12
Carparts.Com Inc reports results for the quarter ended June 30 - Earnings Summary
Carparts.Com Inc PRTS.OQ reported a quarterly adjusted loss of 23 cents per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -15 cents. The mean expectation of two analysts for the quarter was for a loss of 15 cents per share. Wall Stree...Reuters
Tue, Aug 12
EMERGING MARKETS-Latam FX at record high, stocks soar after cooler US inflation buoys sentiment
US, China extend tariff truce by 90 daysColombia bought back $2.96 billion in bondsBrazil July CPI rose 0.26%, below forecastMSCI Latam stocks at five-week peakBy Pranav Kashyap, Sukriti Gupta and Purvi Agarwal Aug 12 (Reuters) - A gauge of Latin American currencies reached a record high, while s...Reuters
Tue, Aug 12
Fate Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Fate Therapeutics Inc FATE.OQ reported a quarterly adjusted loss of 29 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -33 cents. The mean expectation of twelve analysts for the quarter was for a loss of 34 cents per share. W...Reuters
Tue, Aug 12
CoreWeave down after Q2 results
** Shares of AI data center operator CoreWeave CRWV.O fall 7.6% to $138.17 in extended trading** CRWV reports Q2 revenue of $1.21 billion, beating analysts' average estimate of $1.08 billion, according to data compiled by LSEG** Co says revenue backlog was $30.1 billion as of June 30** CRWV'...Reuters
Tue, Aug 12
Verrica Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Verrica Pharmaceuticals Inc VRCA.OQ reported quarterly adjusted earnings of 2 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-3.70. The mean expectation of five analysts for the quarter was for a loss of 70 cents per share....Reuters
Tue, Aug 12
IZEA Worldwide Inc reports results for the quarter ended June 30 - Earnings Summary
IZEA Worldwide Inc IZEA.OQ reported quarterly adjusted earnings of 7 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -13 cents. The lone analyst forecast for the quarter was for earnings of 2 cents per share. Revenue rose 0.4...Reuters
Tue, Aug 12
Urgent.ly Inc reports results for the quarter ended June 30 - Earnings Summary
Urgent.ly Inc ULY.OQ reported a quarterly adjusted loss of $4.50 per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-10.44. The mean expectation of two analysts for the quarter was for a loss of $2.70 per share. Wall Street expected ...Reuters
Tue, Aug 12
PetMed Express plummets as CEO, CFO resign
** Shares of pet drug retailer PetMed Express PETS.O fall 13.7% to $2.69 after market** Co says CEO Sandra Campos and CFO Robyn D'Elia have resigned from their positions and employment with the company** Adds, Chair of the board Leslie Campbell has assumed the role of interim CEO and Douglas Kru...Reuters
Tue, Aug 12
Cenovus in talks with Canadian Indigenous groups to buy MEG Energy, Bloomberg News reports
Aug 12 (Reuters) - Cenovus Energy CVE.TO is in talks with Canadian Indigenous groups to jointly buy MEG Energy MEG.TO, Bloomberg News reported on Tuesday, citing people familiar with the discussions.A group of First Nations and Metis communities, including Chipewyan Prairie First Nation and Heart La...Reuters
Tue, Aug 12
CANADA STOCKS-TSX rises to record high as US inflation data supports Fed rate-cut bets
TSX ends up 0.5% at 27,921.26Edges above last Wednesday's record closing highNine of 10 major sectors notch gainsFinancials add 0.7%, materials end 0.9% higherBy Nikhil Sharma and Fergal Smith Aug 12 (Reuters) - Canada's main stock index posted on Tuesday a new record high, with financial...Reuters
Tue, Aug 12
Compass Therapeutics slides on stock offering launch
** Shares of Compass Therapeutics CMPX.O down 5.3% post-market to $3.00 after equity raise news ** Boston, Massachusetts-based oncology-focused biopharma launches offering of stock and pre-funded warrants; deal size not disclosed ** Co intends to use net proceeds to conduct initial prepara...Reuters
Tue, Aug 12
Kyverna Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Kyverna Therapeutics Inc KYTX.OQ reported a quarterly adjusted loss of 97 cents per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -67 cents. The mean expectation of six analysts for the quarter was for a loss of $1.04 per share. Wall ...Reuters
Tue, Aug 12
LIVE MARKETS-Wall Street rallies as S&P, Nasdaq end at record closing highs
Main US indexes rally; S&P, Nasdaq close at record peaksAll S&P sectors show gains; Comm Svcs leads all sector gainers Dollar slides; crude down >1%; gold edges up; bitcoin up ~0.8%US 10-year Treasury yield edges up to ~4.29%Welcome to the home for real-time coverage of markets brought to...Reuters
Tue, Aug 12
Sellas Life Sciences Group Inc reports results for the quarter ended June 30 - Earnings Summary
Sellas Life Sciences Group Inc SLS.OQ reported a quarterly adjusted loss of 7 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -13 cents. The mean expectation of three analysts for the quarter was for a loss of 8 cents per sha...Reuters
Tue, Aug 12
Lyra Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Lyra Therapeutics Inc LYRA.OQ reported a quarterly adjusted loss of $5.51 per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-37.00. The mean expectation of four analysts for the quarter was for a loss of $6.02 per share. Wall Street...Reuters
Tue, Aug 12
